Greetings! 

SoCalBio Weekly Update

Past Weekly
Updates

Cut Cost of Doing Business

Join the SoCalBio Group Purchasing Program to enjoy significant savings on medical and industrial gas from

  

For more info, call SoCalBio at 

800-418-7079 ext 3 

SoCalBio Partners

 

 

vince

 

 

vince

 

  NP

 

vince

Replenish, Inc.

airgas  

 

Los Angeles/Orange County Biotechnology Center 

vince

 

onelambda 

 SoCalBio Mast  

 

 

trinet

onelambda

officedepot
 

 

Join SoCalBio
Join SoCalBio leaders to promote the biotech and device industries in Los Angeles, Orange County and neighboring communities for job creation and overall economic growth.
Become a Member
Thanks to SoCalBio Media Partners


August 19,  2013


Editor: Ahmed Enany 
President & CEO
Southern California
Biomedical Council

enany@socalbio.org

www.socalbio.org

Register now

SoCalBio Workforce Summit
  

Building the Bioeconomy Talent Pipeline
  August 21, 2013, 8 am to 4 pm

Van de Kamp Innovation Center
2930 Fletcher Drive and San Fernando Road,
Los Angeles CA 90065

Eventbrite - WFS

 

Learn about the state of the bioscience industry in the Greater Los Angeles region. Join our distinguished speakers in the discourse about how our local companies can meet their talent needs to stay competitive

 





Cathy Benko,
Deloitte
Marc Better, PhD
Kite Biopharma
Lennie Ciufo, LAVC
Anthony Davies, PhD, Capricor




Ryan Helwig, Battelle TPP
Tom Lobl, PhD, AMF
Wolfe Noe, PhD, Agensys
Ted Randolph,
Second Sight





Russell Read, PhD, c3bc
Wilie Zuniga,
Grifols Biologicals

 

 

Eventbrite - WFS

Featuring Next Gen. Medtech, Biotech & eHealth Companies
To sponsor or make a business presentation, contact SoCalBio at
800-418-7079 ext 1  -- scbc@socalbio.org
New Funding 
Los Angeles-Based Telemedicine Company SnapMD Closes $600,000 Seed Round 

"We could not be more pleased to have Shea Ventures and Whittier Trust as our lead investors. Along with the high-quality individual investors that also participated, the close of this round is one more validation of our business plan and approach to the market," said SnapMD CEO, Dave Skibinski (photo right). "With the successful close of this investment SnapMD is well positioned to take the next steps with our current sales pipeline, continue to add best-of-breed talent, and solidifies our future technology development plans" .. Read Press Release

Neuromodulation Company SetPoint Medical Secures $27 Million in Venture Funding

Los Angeles startup SetPoint Medical has hauled in $27 million in venture funding to support its neuromodulation device to treat inflammatory diseases, attracting heavyweights like GlaxoSmithKline, Covidien and Boston Scientific. Now, with such high-profile backers lending weight to the technology, the company has reached "an inflection point" in its work to find an alternative to immunosuppressive drugs, CEO Anthony Arnold said ... Learn more about SetPoint Medical
 
BioBeats, a Los Angeles-Based Mobile Health Company, Raises $650,000 in Seed Funding

BioBeats -- a startup that seeks merging entertainment and healthcare -- raised money from investors including Will Smith, Damon Wayans, Scooter Braun, Justin Boreta, entertainment lawyer Ken Hertz, AAM CEO Mark Beaven, Cantora Records, ENIAC Ventures, Zhen Fund, and angel investors Gotham Chopra and Kevin Colleran. www.biobeats.com

The Forest Lake-Based ReVision Optics Closes a $55 Million Funding Round

"We are clearly delighted to complete this strategic financing with such highly regarded healthcare venture investors," said John T. Kilcoyne (photo right), Revision Optics' President and Chief Executive Officer. "Participation by all of our existing investors, Canaan, ProQuest, InterWest and Domain, combined with the capital from new investors JJDC and RMI, provides our company with the necessary financial resources to carry us through the FDA PMA process for the Raindrop Near Vision Inlay and to expand our current commercial footprint outside the U.S.," he added ... Read Press Release

The Los Angeles-Based Meditope Biosciences Announces the Completion of a $3.6 Million Series A Round of Funding


Meditope -- a spinoff of the City of Hope and alumnus of the 2012 SoCalBio Investor Conference -- has raised $3.6M in a Series A financing led by angel investors to advance its proprietary monoclonal antibody (mAb) linker technology platform. "We are grateful to have had the opportunity to be funded by angel investors, who include pioneers in the biotechnology industry and are supportive of our efforts to quickly advance the development of this exciting new technology platform into the clinic," said Stephanie Hsieh (photo right), the company's President & CEO and a leading member of the SoCalBio W3 Group ... Learn more about Meditope Biosciences

  

Second Sight Medical Products Files 

to Raise $10.5 Million

  

The Los Angeles-based medical device company is launching the Argus II. It is the first bionic eye that the FDA approved earlier this year. It was 20 years in the making. The device looks like a sunglass but incorporates a digital camera, which in turn communicates with an implant on the eye. It is aimed at patients suffering from late stage retinitis pigmentosa (RP) ... Read more

  

San Juan Capistrano-Based Startup Caymus Medical Seeks $10 Million

  

Caymus -- a company seeking to develop devices for percutaneous intravascular access and guidewire placement -- has raised $3.9 million so far from 19 investors, according to the filing. Investors' names were not listed and the company didn't specify what it plans to do with the funds .. Read Announcement at MassDevice

New SoCalBio Members
Mesirow Financial (Los Angeles Office) 
 
Mesirow Financial is a diversified financial services firm headquartered in Chicago. Founded in 1937, it is an independent, employee-owned firm with approximately 1,200 employees globally. With expertise in Investment Management, Global Markets, Insurance Services and Consulting, Mesirow Financial strives to meet the financial needs of institutions, public sector entities, corporations and individuals... Learn more
 
AVI-SPL (Cypress)

 AVI-SPL helps customers of all sizes and industries to develop their video communications strategies by providing services that assess, develop and support solutions. ... Learn more

 

Gordon L. Schooly, Ph.D., LLC (San Diego) 
Provides global regulatory and clinical development strategy and execution. FDA, EMA, Health Canada and Australia Health Authority representation. Biostatistics and clinical data management, electronic regulatory submissions including CDISC and C-Path, analytics support to government health agencies and private health care providers .. Learn more  
 
Citrus College (Glendora)

A community college in the San Gabriel Valley ... Learn more

Sponsored Events
  
October 8 - 9, 2013 in San Francisco, CA
-----------------------------------------------------------------------------------------
 
November 11 - 13  in Beijing, China
Interview
MassDevice Interview James Mazzo Regarding His Move to Versant Ventures
 
According to MassDevice "James Mazzo has put 35 years into the optics and ophthalmology business, so it was no surprise that he got involved with AcuFocus and its device for treating presbyopia. Mazzo, who stepped down from leading Abbott Medical Optics earlier this year, added another title to his resume that's more of a departure: He's the 1st "operating partner" at Versant Ventures" ... Read Interview 
Reports

Silicon Valley Bank Report Says Big Device M&A Exits Held Their Own in 2012

 

Silicon Valley Bank's annual healthcare report notes that the medical device industry generated 17 "Big Exit" acquisitions in 2012, the same as in 2011. Device company IPOs have been all but nonexistent, so the only option for an exit strategy in most cases has become M&A... Read Silicon Valley Bank Report

Digital Health
The Los Angeles-Based Holomic Is Among the Finalists Selected for the Nokia Sensing XCHALLENGE
 

Holomic, a UCLA digital health spinoff,  is competing for the $525,000 grand prize and up to five additional $120,000 prizes in the Nokia Sensing XCHALLENGE. The purpose of the XCHALLENGE is "to accelerate the availability of hardware sensors and software sensing technology that individuals use to access, understand, and improve their health and well-being. Innovation in sensing is an important component to creating a means for appealing, usable, smarter digital health solutions" ... Read more

Retinal Prosthetics
Los Angeles-Based Second Sight Gains CMS Reimbursement for its Retinal Prosthesis
 
Second Sight Medical Products, Inc., the leading developer of retinal prostheses for the blind, announced that The Argus II Retinal Prosthesis System (Argus II) has been approved by the Centers for Medicare and Medicaid Services (CMS) for both a new technology add-on payment (inpatient setting of care) and a transitional pass through payment (outpatient setting of care) beginning October 1, 2013. These payments are designed to support timely access to innovative technologies for Medicare beneficiaries .. Read more
Crowdfunding 

USC Creates Virtual Sprouts, A Mobile Gardening and Cooking Game, to Teach Kids About Healthy Living

 

USC preventive medicine, artificial intelligence, cinematographic arts, game development, and USC STEM education teamed up to find ways to help kids, particularly minority children, about healthy living. The result was the development of an award winning game, Virtual Sprouts. It is a mobile gardening and cooking game which will be given free to minority children of Los Angeles to teach them about the magic of gardening, how to grow fruits and vegetables and how to cook tasty and healthy dishes. Virtual Sprouts is championed by AMI - USC which is partnering with WhenYouWish.com to help Virtual Sprouts launch its first crowdfunding campaign ...Learn more


Inhaled Insulin

Positive Data on MannKind's Afrezza

 

The Valencia-based MannKind Corp. recently announced encouraging results from the much awaited phase III Affinity studies on its lead candidate Afrezza. Afrezza is being developed for the treatment of type I or type II diabetes. Afrezza met primary end points in both the studies ... Read more

  See also: MannKind's Steady Progression Towards FDA Approval Continues Unabated

Patent Litigation
The Aliso Viejo-Based Avanir and Novartis' Generic Drug Arm - Sandoz - Settle Neudexta Litigation
 
Avanir Pharmaceuticals, Inc. recently entered into a settlement agreement with Novartis AG's generic arm Sandoz, Inc. to resolve their patent litigation regarding Neudexta. Sandoz had filed an abbreviated new drug application (ANDA) to get its generic version of Avanir's Nuedexta approved ... Read more 
Join SoCalBio

Become a SoCalBio Member and Save Money by Utlizing the SoCalBio Group Purchasing Program

Jobs Available

Phenomenex (Torrance)

ResearchDx (Irvine)
Avita Medical (Northridge)
Aubrey Group (Irvine)

Second Sight Medical Products (Sylmar)

Alfred Mann Foundation for Scientific 

Research (Santa Clarita)

WaveTec Vision (Aliso Viejo)

Response Genetics (Los Angeles)

 Tribogenics (Marina del Rey)

Click to access more info
About SoCalBio 
 
SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio